Free Trial

Autonomix Medical Q4 2024 Earnings Report

Autonomix Medical logo
$1.70 -0.04 (-2.30%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Autonomix Medical EPS Results

Actual EPS
-$6.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Autonomix Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Autonomix Medical Announcement Details

Quarter
Q4 2024
Time
N/A

Conference Call Resources

Remove Ads

Autonomix Medical Earnings Headlines

Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
See More Autonomix Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Autonomix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Autonomix Medical and other key companies, straight to your email.

About Autonomix Medical

Autonomix Medical (NASDAQ:AMIX), a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

View Autonomix Medical Profile

More Earnings Resources from MarketBeat